Illinois residents who purchased a generic drug between May 2009 and December 2019 could be eligible for payouts as part of a series of allegations that drug companies conspired to manipulate prices.
Illinois Attorney General Kwame Raoul joined 43 other states and territories seeking approval for a $400 million settlement with Sandoz Inc. and Fougera Pharmaceuticals Inc. following allegations “the generic drug manufacturers engaged in widespread, long-running conspiracies to artificially inflate and manipulate prices, reduce competition and unreasonably restrain trade with regard to numerous generic prescription drugs.”
The settlement, which still needs to be approved by a judge, will bring roughly $469 million in claims as Sandoz “has agreed to meaningful injunctive terms including a series of internal reforms to ensure fair competition and compliance with antitrust laws,” Raoul said.
“At a time of skyrocketing costs for Americans, generic drug companies colluded with each other to raise prices on needed medications simply to line their own pockets,” Raoul said in a statement. “I am pleased with today’s settlement with Sandoz and will continue to hold drug manufacturers accountable for their unfair and unlawful practices.”
Who’s eligible to file a claim?
Illinoisans who purchased a generic prescription drug between May 2009 and December 2019 could be eligible for compensation.
To determine eligibility, residents are encouraged to call 1-866-290-0182, email info@AGGenericDrugs.com or visit www.AGGenericDrugs.com.
Which drugs can you file a claim for?
A list of generic drugs purchasers could be eligible for payouts in can be found here. The list was last updated on Sept. 21.
How can you file a claim?
There are multiple options for filing a claim.
The first option is called the “simplified claim option” and it only requires you to “certify” that you bought a certain generic prescription drug in the U.S. during the eligible timeframe.
No proof of purchase is necessary and the payment amount will be “an equal share of the funds available to be distributed” to each person who files such a claim.
The second option is available for those who have additional purchase information and requires a claimant to not only certify their purchase but “provide the estimated total you paid out of pocket.”
“This option may be more appropriate for you if you paid a significant amount out-of-pocket for these purchases,” the claim website states.
Those who file the second option will have their share “calculated based on the amount you paid, from the funds available to be distributed from the Settlements where you are an eligible claimant.”
“It is possible your payment amount will be higher than the equal share you would receive by selecting Claim Option 1, and will not be less than if you choose Claim Option 1,” the website notes.
Claims can be filed here.
What else to know
It follows three separate lawsuits filed by Raoul and a coalition of states against nearly 50 large generic drug manufacturers “alleging they engaged in a broad, coordinated and systematic campaign to conspire with each other to fix prices, allocate markets and rig bids for hundreds of different generic drugs.” The drugs include statins, ace inhibitors, beta blockers, antibiotics, anti-depressants, contraceptives and non-steroidal anti-inflammatory drugs used to treat everything from from basic infections to diabetes, cancer, epilepsy, multiple sclerosis, HIV, ADHD and more.
According to Raoul, in some instances, the coordinated price increases were over 1,000%.
“These lawsuits allege multiple conspiracies in which executives of competing companies would negotiate illegal agreements during industry dinners, trade shows and customer conferences. They also communicated via frequent telephone calls, emails and text messages, where they discussed allocating customers and coordinating price increases on the products they had in common. Throughout these conspiracies, defendants used terms like “fair share,” “playing fair” and “rules of engagement” to describe how they unlawfully discouraged competition, raised prices and enforced an ingrained culture of collusion.
Already, settlements have been agreed to with drugmakers Glenmark, Lannett, Bausch, Apotex and Heritage totaling approximately $96.5 million.
The state said it is preparing for an anticipated trial in 2027.
Hence then, the article about illinois residents who purchased generic drugs could be eligible for a payout was published today ( ) and is available on NBC Chicago ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Illinois residents who purchased generic drugs could be eligible for a payout )
Also on site :